Obstacles and opportunities in Chinese pharmaceutical innovation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Obstacles and opportunities in Chinese pharmaceutical innovation

Published:2017-03-24 Issue:1 Volume:13 Page:
ISSN:1744-8603
Container-title:Globalization and Health
language:en
Short-container-title:Global Health

Author:

Ni Jingyun,Zhao Junrui,Ung Carolina Oi Lam,Hu Yuanjia,Hu Hao,Wang Yitao

Funder

University of Macau

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12992-017-0244-6.pdf

Reference47 articles.

1. Kaitin KI. Deconstructing the drug development process: the new face of innovation. Clin Pharmacol Ther. 2010;87(3):356–61.

2. Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11:191–200.

3. Hughes B. Evolving R&D for emerging markets. Nat Rev Drug Discov. 2010;9:417–20.

4. Gautam A, Yang S. Market watch: a framework for biomedical innovation in emerging markets. Nat Rev Drug Discov. 2014;13:646–7.

5. Frew SE, Sammut SM, Shore AF, Ramjist JK, Al-Bader S, Rezaie R, et al. Chinese health biotech and the billion-patient market. Nat Biotechnol. 2008;26:37–53.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Patent Analysis on Nano Drug Delivery Systems;Recent Patents on Nanotechnology;2024-07-09

2. A call to rethink the necessity of and challenges facing academic research organizations in the new era of drug innovation in China;Drug Discovery Today;2024-04

3. Does the decoupling of industry associations from administrative authorities promote enterprise innovation? Evidence from China;Applied Economics Letters;2024-01-08

4. Bridging the new drug access gap between China and the United States and its related policies;Frontiers in Pharmacology;2024-01-08

5. Pharmacy Education, Practice, and Research in China;Handbook of Medical and Health Sciences in Developing Countries;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3